Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) EPS (Basic) (2016 - 2025)

Organogenesis Holdings (ORGO) has 10 years of EPS (Basic) data on record, last reported at $0.32 in Q4 2025.

  • For Q4 2025, EPS (Basic) rose 700.0% year-over-year to $0.32; the TTM value through Dec 2025 reached $0.16, up 900.0%, while the annual FY2025 figure was $0.16, 1700.0% up from the prior year.
  • EPS (Basic) reached $0.32 in Q4 2025 per ORGO's latest filing, up from $0.11 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.39 in Q4 2021 and bottomed at -$0.17 in Q1 2025.
  • Average EPS (Basic) over 5 years is $0.05, with a median of $0.04 recorded in 2023.
  • Peak YoY movement for EPS (Basic): soared 1107.3% in 2023, then plummeted 750.0% in 2025.
  • A 5-year view of EPS (Basic) shows it stood at $0.39 in 2021, then tumbled by 84.62% to $0.06 in 2022, then plummeted by 81.66% to $0.01 in 2023, then surged by 263.52% to $0.04 in 2024, then soared by 700.0% to $0.32 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Basic) were $0.32 in Q4 2025, $0.11 in Q3 2025, and -$0.1 in Q2 2025.